Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.

● The company has a poor ESG score according to Refinitiv, which ranks companies by sector.


Strengths

● Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the past twelve months, EPS forecast has been revised upwards.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 60.52 times its estimated earnings per share for the ongoing year.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Most analysts recommend that the stock should be sold or reduced.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.